Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
Prashant Gajwani1, David J Muzina2, David E Kemp3, Keming Gao1, Joseph R Calabrese11Case Western Reserve University (CWRU) School of Medicine, 2Cleveland Clinic Lerner College of Medicine of CWRU, 3Case Western Reserve University, Cleveland OH, USAAbstract: The essential features of bipolar affectiv...
Guardado en:
Autores principales: | Prashant Gajwani, David J Muzina, David E Kemp, Keming Gao, Joseph R Calabrese |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05c22c74891d4858a3d09afe0db2ebd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili N
Publicado: (2012) -
Role of extended release quetiapine in the management of bipolar disorders
por: Rayan K Al Jurdi, et al.
Publicado: (2010) -
Quetiapine monotherapy for bipolar depression
por: Michael E Thase
Publicado: (2008) -
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009) -
Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
por: Laura Gedge, et al.
Publicado: (2010)